The President of Brazil, Luiz Inácio Lula da Silva, and the Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, have issued a joint appeal to the leaders of the G7, G20, BRICS, and all sovereign nations to conclude the final stages of a comprehensive global pandemic preparedness framework. In an open letter released from Geneva and Brasília, the two leaders emphasized that while significant progress has been made since the height of the COVID-19 crisis, the world remains vulnerable without a finalized Pathogen Access and Benefit-Sharing (PABS) annex. This technical and political instrument is described as the "last piece of the puzzle" required to operationalize the WHO Pandemic Agreement, a landmark international treaty aimed at preventing a repeat of the catastrophic loss of life and economic devastation witnessed between 2020 and 2023.
The appeal comes at a critical juncture for international diplomacy. Following the 77th World Health Assembly in May 2024, where Member States agreed to extend negotiations after failing to reach a final consensus on certain equity-related clauses, a decisive meeting of the Intergovernmental Negotiating Body (INB) is scheduled for July 6 to 17. The joint statement from President Lula and Dr. Tedros serves as a high-level directive to negotiators, urging them to prioritize solidarity over caution and to treat the July session not as a mere milestone, but as a hard deadline for completion.
The Economic and Human Toll of Unpreparedness
To underscore the gravity of the negotiations, the WHO and the Brazilian presidency of the G20 have pointed to staggering data regarding the impact of the COVID-19 pandemic. According to WHO estimates, the total loss of life directly and indirectly attributable to the pandemic reached approximately 20 million people. Beyond the human tragedy, the International Monetary Fund (IMF) has calculated that the pandemic cost the global economy more than $13 trillion in lost output. These losses were felt universally, manifesting as shuttered businesses, fractured supply chains, and a massive disruption to global education that may impact a generation of workers.
The leaders argue that the investment required to build a functional PABS system is negligible compared to the cost of future inaction. By establishing a framework that allows for the early detection of outbreaks, the international community can contain threats at their source. Current real-world examples, such as the ongoing fight against Ebola outbreaks in Africa—where responders often work without approved vaccines or cures—serve as a reminder that the threat of infectious disease is a constant reality rather than a distant abstraction.
The PABS System: A Bargain of Equity and Strategy
At the heart of the current diplomatic deadlock is the Pathogen Access and Benefit-Sharing (PABS) annex. The system is built on a reciprocal "fair bargain" designed to solve a recurring problem in global health: during an outbreak, countries that share genetic data or physical samples of a dangerous pathogen often find themselves at the back of the line when the resulting vaccines and treatments are manufactured.
The PABS framework aims to create a standardized, predictable set of rules. Under this system, countries would commit to the rapid sharing of pathogen information and materials. In exchange, they would receive guaranteed, equitable access to the "benefits" derived from that sharing—specifically, a percentage of the resulting medical countermeasures, such as diagnostic tests, antiviral treatments, and vaccines, provided on an equal footing.
President Lula and Dr. Tedros have framed this not as an act of charity, but as a core strategy for global security. They argue that containing a virus where it first emerges is the most effective way to protect all nations, regardless of their wealth. Brazil’s leadership in the G20 in 2024 was instrumental in formalizing the recognition of inequality as a primary driver of pandemic risk. The joint letter asserts that legal certainty and predictability provided by the PABS system would benefit both governments and the private sector by replacing "case-by-case" improvisation with a stable, pre-negotiated framework.
Addressing Sovereignty and Technical Barriers
One of the most significant hurdles in the negotiation process has been the concern among some nations that a global pandemic agreement might infringe upon national sovereignty. The joint letter addresses these concerns directly, citing Article 22, paragraph 2 of the draft Agreement. The text explicitly states that the WHO is not granted the authority to direct national laws, alter domestic policies, or mandate specific public health measures such as lockdowns, travel restrictions, or mandatory vaccinations. These decisions remain the exclusive domain of sovereign states.
The leaders emphasized that the remaining issues are no longer merely technical; they are political. The "hardest questions"—including how benefits are defined, how the system is governed, and how operational equity is guaranteed—require a mandate from the highest levels of government. Negotiators have been urged to move beyond "caution" and seek "consensus with courage," signaling that the finalization of the annex is a national security priority for all involved.
A Chronology of the Pandemic Agreement
The path toward a global pandemic treaty has been characterized by intense diplomacy and significant milestones:
- December 2021: A special session of the World Health Assembly (WHA) establishes the Intergovernmental Negotiating Body (INB) to draft and negotiate a WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response.
- 2022-2023: Multiple rounds of negotiations take place, focusing on strengthening the International Health Regulations (IHR) and drafting the core tenets of the Pandemic Agreement.
- May 2024: At the 77th World Health Assembly, Member States adopt a package of amendments to the IHR (2005) and agree to extend the mandate of the INB to finish the Pandemic Agreement and its annexes.
- July 6–17, 2024: The scheduled period for the next round of negotiations, which President Lula and Dr. Tedros have identified as the final window for concluding the PABS annex.
Future Risks: Why Urgency is Paramount
The call for urgency is backed by scientific modeling suggesting that the frequency of pandemic-level events is likely to increase. Experts estimate there is nearly a 25% chance of another major pandemic occurring within the next decade. Several factors are contributing to this heightened risk profile:
- Climate Change and Land Use: As global temperatures rise and habitats are destroyed, the geographical range of disease-carrying vectors (such as mosquitoes and ticks) expands, and the likelihood of zoonotic spillover—where viruses jump from animals to humans—increases.
- Biotechnology Risks: While advances in biotech are essential for developing cures, they also present risks of accidental or deliberate release of pathogens, particularly if biosafety standards are not applied uniformly across the globe.
- Global Connectivity: The speed of modern travel means that an outbreak in a remote region can reach every continent within 24 to 48 hours, rendering old assumptions about "distant threats" obsolete.
By finalizing the PABS annex now, the WHO and its Member States aim to move from a "reactive" posture to a "proactive" one. The leaders argue that the world cannot afford to wait for the next crisis to negotiate the rules of engagement.
Analysis of Global Implications
The successful conclusion of the Pandemic Agreement would represent one of the most significant achievements in the history of multilateralism and public health. Historically, the international community has demonstrated the ability to unite against common threats, as seen in the eradication of smallpox and the near-elimination of polio. However, the COVID-19 era exposed deep fissures in global solidarity, particularly regarding "vaccine nationalism" and the hoarding of medical supplies by wealthier nations.
The PABS annex is designed to bridge this "equity gap." For the G7 nations, the agreement offers a streamlined, legal framework for accessing the data necessary for their advanced pharmaceutical industries to develop life-saving tools. For the BRICS and other developing nations, it offers a guarantee that they will not be excluded from the benefits of the science they helped facilitate.
If the July negotiations succeed, the Agreement will enter into force, providing the WHO and Member States with a robust infrastructure to monitor, report, and respond to pathogens with pandemic potential. If they fail, the "promise" made in the wake of COVID-19—to never again face a pandemic unprepared—remains unkept.
As the July 17 deadline approaches, the eyes of the global health community are on the heads of state of the world’s most powerful nations. The joint letter from President Lula and Dr. Tedros makes it clear that the technical work is largely complete; what remains is a choice of political will. The legacy of the current generation of leaders may well be defined by their ability to finalize this agreement and protect humanity from the inevitable biological challenges of the 21st century.
